We are live on ! Find out more
NUTX icon

Nutex Health

131 hedge funds and large institutions have $267M invested in Nutex Health in 2026 Q1 according to their latest regulatory filings, with 40 funds opening new positions, 52 increasing their positions, 27 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed

93% more repeat investments, than reductions

Existing positions increased: 52 | Existing positions reduced: 27

59% more capital inflows, than outflows

Capital inflows: $131M | Capital outflows: $82.3M

54% more first-time investments, than exits

New positions opened: 40 | Existing positions closed: 26

10% more funds holding

Funds holding: 119 → 131 (+12)

2.91% more ownership

Funds ownership: 37.36% → 40.27% (+2.9%)

100% less funds holding in top 10

Funds holding in top 10: 3 → 0 (-3)

Holders
131
Holders Change
+12
Holders Change %
+10.08%
% of All Funds
1.59%
Holding in Top 10
–
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-100%
% of All Funds
–
New
40
Increased
52
Reduced
27
Closed
26
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

NUTX Hedge Fund Activity: Q1 2026 in Review

131 of the 8,232 institutional investors tracked by Wall St. Rank reported a position in Nutex Health (NUTX) for Q1 2026, worth a combined $267M — down 39% from $435M a quarter earlier.

Buyers outnumbered sellers: 40 funds opened new NUTX positions and 26 closed out — a net gain of 14 holders — while 52 added to existing stakes and 27 trimmed.

The largest buyer was BlackRock, adding an estimated $12M. The largest seller was Topline Capital Management, cutting an estimated $61M.

  • 131 institutional investors held Nutex Health (NUTX) as of Q1 2026, up from 119 in Q4 2025.
  • Funds reported $267M of Nutex Health stock for Q1 2026, down 39% quarter-over-quarter.
  • 40 funds opened new Nutex Health positions in Q1 2026 and 26 closed out, a net change of +14 holders.
  • The largest Nutex Health buyer in Q1 2026 was BlackRock, an estimated $12M added.
  • The largest Nutex Health seller in Q1 2026 was Topline Capital Management, an estimated $61M sold.

Based on aggregated 13F filings for Q1 2026.